help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 14, 2008
Endocrinology, doi:10.1210/en.2007-1320
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
149/5/2219    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohankumar, K. M.
Right arrow Articles by Lobie, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohankumar, K. M.
Right arrow Articles by Lobie, P. E.

Submitted on September 25, 2007
Accepted on February 6, 2008

Transcriptional activation of STAT3 and STAT5B partially mediate HOXA1 stimulated oncogenic transformation of the immortalised human mammary epithelial cell

Kumarasamypet M. Mohankumar, Jo K. Perry, Nagarajan Kannan, Kimitoshi Kohno, Peter D. Gluckman, B. Starling Emerald, and Peter E. Lobie*

The Liggins Institute and National Research Centre for Growth and Development, University of Auckland, Auckland, New Zealand; Departments of Molecular Biology and Surgery, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan

* To whom correspondence should be addressed. E-mail: p.lobie{at}auckland.ac.nz.

We have previously demonstrated that the p44/42 MAP kinase pathway is one pathway involved in HOXA1 stimulated oncogenesis. However, inhibition of MEK1 does not completely prevent HOXA1 stimulated oncogenic transformation, suggesting the involvement of additional signal transduction pathways. Here, we report that forced expression of HOXA1 in immortalised human mammary epithelial cells significantly increased levels of STAT3, 5A and 5B mRNA by transcriptional upregulation. The protein levels of STAT3 and 5B (but not STAT5A), and protein phosphorylation levels of STAT3 and 5B were significantly increased by forced expression of HOXA1. Forced expression of STAT3 or STAT5B was sufficient to oncogenically transform an immortalised human mammary epithelial cell line. Accordingly, inhibition of STAT3 or STAT5B activity with dominant negative STAT3 or STAT5B abrogated the ability of HOXA1 to stimulate cell proliferation, survival, oncogenic transformation and generation of large disorganized multiacinar structures in 3D culture. These results suggest that HOXA1 partially mediates oncogenic transformation of the immortalised human mammary epithelial cell through modulation of the STAT3 and STAT5B pathways.


Key words: HOXA1 • Transcriptional activation • STAT3 • STAT5B • Oncogenic transformation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society